BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 14709271)

  • 1. Clinical inquiries. Is folate supplementation indicated for patients with CAD?
    Hecox K; Hale W; Mackler L; Gill JM
    J Fam Pract; 2004 Jan; 53(1):61-3. PubMed ID: 14709271
    [No Abstract]   [Full Text] [Related]  

  • 2. Folic acid improves endothelial function in coronary artery disease via mechanisms largely independent of homocysteine lowering.
    Doshi SN; McDowell IF; Moat SJ; Payne N; Durrant HJ; Lewis MJ; Goodfellow J
    Circulation; 2002 Jan; 105(1):22-6. PubMed ID: 11772871
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of homocysteine-lowering treatment with folic acid plus vitamin B on cerebrovascular atherosclerosis and white matter abnormalities as determined by MRA and MRI: a placebo-controlled, randomized trial.
    Vermeulen EG; Stehouwer CD; Valk J; van der Knaap M; van den Berg M; Twisk JW; Prevoo W; Rauwerda JA
    Eur J Clin Invest; 2004 Apr; 34(4):256-61. PubMed ID: 15086356
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Folate supplementation and cardiovascular disease.
    Spence JD
    Lancet; 2006 Apr; 367(9518):1238; author reply 1238-9. PubMed ID: 16631875
    [No Abstract]   [Full Text] [Related]  

  • 5. The effect of postmenopausal hormone therapy with or without folic acid supplementation on serum homocysteine level.
    Toprak A; Erenus M; Ilhan AH; Haklar G; Fak AS; Oktay A
    Climacteric; 2005 Sep; 8(3):279-86. PubMed ID: 16390760
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Folic acid and vitamin B12 are more effective than vitamin B6 in lowering fasting plasma homocysteine concentration in patients with coronary artery disease.
    Lee BJ; Huang MC; Chung LJ; Cheng CH; Lin KL; Su KH; Huang YC
    Eur J Clin Nutr; 2004 Mar; 58(3):481-7. PubMed ID: 14985687
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Secondary prevention with folic acid: effects on clinical outcomes.
    Liem A; Reynierse-Buitenwerf GH; Zwinderman AH; Jukema JW; van Veldhuisen DJ
    J Am Coll Cardiol; 2003 Jun; 41(12):2105-13. PubMed ID: 12821232
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High- but not low-dose folic acid improves endothelial function in coronary artery disease.
    Moat SJ; Madhavan A; Taylor SY; Payne N; Allen RH; Stabler SP; Goodfellow J; McDowell IF; Lewis MJ; Lang D
    Eur J Clin Invest; 2006 Dec; 36(12):850-9. PubMed ID: 17087779
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical use and rational management of homocysteine, folic acid, and B vitamins in cardiovascular and thrombotic diseases.
    Stanger O; Herrmann W; Pietrzik K; Fowler B; Geisel J; Dierkes J; Weger M
    Z Kardiol; 2004 Jun; 93(6):439-53. PubMed ID: 15252738
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Homocysteine-lowering therapy does not affect inflammatory markers of atherosclerosis in patients with stable coronary artery disease.
    Bleie Ø; Semb AG; Grundt H; Nordrehaug JE; Vollset SE; Ueland PM; Nilsen DW; Bakken AM; Refsum H; Nygård OK
    J Intern Med; 2007 Aug; 262(2):244-53. PubMed ID: 17645592
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of homocysteine-lowering vitamin therapy on long-term outcome of patients with coronary artery disease.
    Mager A; Orvin K; Koren-Morag N; Lev IE; Assali A; Kornowski R; Shohat M; Battler A; Hasdai D
    Am J Cardiol; 2009 Sep; 104(6):745-9. PubMed ID: 19733705
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Folate reduces homocysteine levels and lowers rate of restenosis.
    SoRelle R
    Circulation; 2001 Dec; 104(24):E9050-60. PubMed ID: 11764786
    [No Abstract]   [Full Text] [Related]  

  • 13. The importance of (early) folate status to primary and secondary coronary artery disease prevention.
    Muskiet FA
    Reprod Toxicol; 2005; 20(3):403-10. PubMed ID: 15964170
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Homocysteine and progression of coronary artery disease.
    Skibińska E; Sawicki R; Lewczuk A; Prokop J; Musiał W; Kowalska I; Mroczko B
    Kardiol Pol; 2004 Mar; 60(3):197-205. PubMed ID: 15156215
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Folate supplementation and cardiovascular disease.
    Davey Smith G; Ebrahim S
    Lancet; 2005 Nov; 366(9498):1679-81. PubMed ID: 16291049
    [No Abstract]   [Full Text] [Related]  

  • 16. Effects of metoprolol and diltiazem on plasma homocysteine levels in patients with isolated coronary artery ectasia.
    Demir M; Ozaydin M; Varol E; Doğan A; Altinbaş A
    Anadolu Kardiyol Derg; 2009 Feb; 9(1):69-70. PubMed ID: 19196583
    [No Abstract]   [Full Text] [Related]  

  • 17. Gene--nutrition interactions in coronary artery disease: correlation between the MTHFR C677T polymorphism and folate and homocysteine status in a Korean population.
    Huh HJ; Chi HS; Shim EH; Jang S; Park CJ
    Thromb Res; 2006; 117(5):501-6. PubMed ID: 15935452
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum levels of folate, vitamin B12 and homocysteine in complete hydatidiform mole.
    Harma M; Harma M; Kocyigit A; Yurtseven S; Demir N
    J Reprod Med; 2004 Apr; 49(4):285-8. PubMed ID: 15134154
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Folate supplementation and cardiovascular disease.
    Stampfer M; Rimm E; Willett W
    Lancet; 2006 Apr; 367(9518):1237-8; author reply 1238-9. PubMed ID: 16631874
    [No Abstract]   [Full Text] [Related]  

  • 20. Heart lines. Flexible arteries and folic acid.
    Harv Heart Lett; 1999 Nov; 10(3):5-6. PubMed ID: 10521896
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.